These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30598020)

  • 1. Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam.
    Ngo CQ; Thi Bui T; Vu GV; Chu HT; Phan PT; Ngoc Pham H; Vu GT; Nguyen LH; Ha GH; Tran BX; Latkin CA; Ho CSH; Ho RCM
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30598020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.
    Ornek T; Tor M; Altın R; Atalay F; Geredeli E; Soylu O; Erboy F
    Int J Med Sci; 2012; 9(4):285-90. PubMed ID: 22701335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
    Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
    COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors and comorbidities affecting the cost of hospital-treated COPD.
    Deniz S; Şengül A; Aydemir Y; Çeldir Emre J; Özhan MH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3023-3030. PubMed ID: 27980399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.
    Perera PN; Armstrong EP; Sherrill DL; Skrepnek GH
    COPD; 2012 Apr; 9(2):131-41. PubMed ID: 22409371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic outcomes among chronic obstructive pulmonary disease Vietnamese patients: Approach considerations from a social perspective.
    Vu TQ; Vo TQ
    J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S64-S74. PubMed ID: 31369536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
    Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease.
    Chen YH; Yao WZ; Cai BQ; Wang H; Deng XM; Gao HL; Huang JS; Wang XM
    Chin Med J (Engl); 2008 Apr; 121(7):587-91. PubMed ID: 18466676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer].
    Zhu ML; Cai BQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):258-61. PubMed ID: 19576037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
    Zhang J; Yao W; You X; Liu T; Liu Y
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
    [No Abstract]   [Full Text] [Related]  

  • 17. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
    Friedman M; Menjoge SS; Anton SF; Kesten S
    Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD-A Report From the Population-Based OLIN COPD Study.
    Jansson SA; Backman H; Rönmark E; Lundbäck B; Lindberg A
    COPD; 2015 Aug; 12(4):381-9. PubMed ID: 25415366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors contributing to high-cost hospital care for patients with COPD.
    Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.